½ÃÀ庸°í¼­
»óǰÄÚµå
1418350

¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ÷°¡Á¦ ½ÃÀå º¸°í¼­ : µ¿Çâ, ¿¹Ãø ¹× °æÀï ºÐ¼®(2030³â)

Biopharmaceuticals Excipients Market Report: Trends, Forecast and Competitive Analysis to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Lucintel | ÆäÀÌÁö Á¤º¸: ¿µ¹® 150 - page report | ¹è¼Û¾È³» : 3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¹ÙÀÌ¿ÀÀǾàǰ ÷°¡Á¦ µ¿Çâ ¹× Àü¸Á

¼¼°è ¹ÙÀÌ¿ÀÀǾàǰ ÷°¡Á¦ ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö 5.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³»°í, 2030³â±îÁö ¾à 40¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ´Ù±â´É ÷°¡Á¦ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí Á¦¾à ȸ»ç°¡ Á¦³×¸¯ ½ÃÀå¿¡ ÁýÁßÇϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ¼¼°è ¹ÙÀÌ¿ÀÀǾàǰ ÷°¡Á¦ ½ÃÀåÀÇ ¹Ì·¡´Â °¡¿ëÈ­ ¹× °è¸éȰ¼ºÁ¦/À¯È­Á¦, Æú¸®¿Ã, ź¼öÈ­¹° ½ÃÀå¿¡¼­ ±âȸ°¡ ÀÖÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹ÙÀÌ¿ÀÀǾàǰ ÷°¡Á¦ ½ÃÀå ÀλçÀÌÆ®

LucintelÀº ´Ü¹éÁú Ä¡·áÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ź¼öÈ­¹°ÀÌ ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ºÎ¹®À¸·Î ³²À» °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù.

ºÏ¹Ì´Â ¹ÙÀÌ¿À ÀǾàǰ Á¦Á¶¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô±â ¶§¹®¿¡ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ±Ô¸ð°¡ Å« Áö¿ªÀ¸·Î ³²À» °ÍÀÔ´Ï´Ù.

ÀÚÁÖ ¹¯´Â Áú¹®

Q1. ½ÃÀå ±Ô¸ð´Â?

A1. ¼¼°è ¹ÙÀÌ¿À ÀǾàǰ ÷°¡Á¦ ½ÃÀåÀº 2030³â±îÁö ¾à 40¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Q2. ½ÃÀå ¼ºÀå Àü¸ÁÀº?

A2. ¼¼°è ¹ÙÀÌ¿ÀÀǾàǰ ÷°¡Á¦ ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 5.6%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Q3. ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?

A3.ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ´Ù±â´É ÷°¡Á¦ äÅÃÀÌ Áõ°¡Çϰí Á¦¾à ȸ»ç°¡ Á¦³×¸¯ ½ÃÀå¿¡ ÁýÁßÇϰí ÀÖ´Ù´Â °ÍÀÔ´Ï´Ù.

Q4. ½ÃÀåÀÇ ÁÖ¿ä ºÎ¹®Àº?

A4. ¹ÙÀÌ¿À ÀǾàǰ ÷°¡Á¦ ½ÃÀåÀÇ ¹Ì·¡´Â °¡¿ëÈ­/°è¸éȰ¼ºÁ¦/À¯È­Á¦, Æú¸®¿Ã, ź¼öÈ­¹° ½ÃÀå¿¡¼­ ±âȸ°¡ ÀÖ°í À¯¸ÁÇÕ´Ï´Ù.

Q5. ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº?

A5. ¹ÙÀÌ¿À ÀǾàǰ ÷°¡Á¦ ÁÖ¿ä ±â¾÷Àº ´ÙÀ½°ú °°½À´Ï´Ù.

  • Merck
  • Colorcon
  • BASF
  • Associated British Foods
  • Signet Excipients
  • Sigachi Industries
  • Spectrum Chemical Manufacturing
  • Roquette Freres
  • IMCD
  • Clariant

Q6. ÇâÈÄ °¡Àå Å« ½ÃÀå ºÎ¹®Àº?

A6.LucintelÀº ´Ü¹éÁú Ä¡·áÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ź¼öÈ­¹°ÀÌ ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ºÎ¹®À¸·Î ³²À» °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù.

Q7. ÇâÈÄ 5³â°£ °¡Àå Å« ½ÃÀåÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â Áö¿ªÀº?

A7. ºÏ¹Ì´Â ¹ÙÀÌ¿À ÀǾàǰ Á¦Á¶¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô±â ¶§¹®¿¡ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ±Ô¸ð°¡ Å« Áö¿ªÀ¸·Î ³²À» °ÍÀÔ´Ï´Ù.

Q8. º¸°í¼­ Ä¿½ºÅ͸¶ÀÌ¡ÀÌ °¡´ÉÇѰ¡?

A8. ³×. LucintelÀº Ãß°¡ ºñ¿ë¾øÀÌ 10%ÀÇ »ç¿ëÀÚ Á¤ÀǸ¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ÷°¡Á¦ ½ÃÀå : ½ÃÀå ¿ªÇÐ

  • ¼­·Ð, ¹è°æ, ºÐ·ù
  • °ø±Þ¸Á
  • ¾÷°è ÃËÁø¿äÀΰú °úÁ¦

Á¦3Àå ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®(2018-2030³â)

  • °Å½Ã°æÁ¦ µ¿Çâ(2018-2023³â)°ú ¿¹Ãø(2024-2030³â)
  • ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ÷°¡Á¦ ½ÃÀå µ¿Çâ(2018-2023) ¹× ¿¹Ãø(2024-2030)
  • Á¦Ç°º° ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ÷°¡Á¦ ½ÃÀå
    • ¿ëÇØÁ¦ ¹× °è¸éȰ¼ºÁ¦/À¯È­Á¦
    • Æú¸®¿Ã
    • ź¼öÈ­¹°

Á¦4Àå Áö¿ªº° ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®(2018-2030³â)

  • Áö¿ªº° ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ÷°¡Á¦ ½ÃÀå
  • ºÏ¹ÌÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ÷°¡Á¦ ½ÃÀå
  • À¯·´ÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ÷°¡Á¦ ½ÃÀå
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ÷°¡Á¦ ½ÃÀå
  • ±âŸ Áö¿ªÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ÷°¡Á¦ ½ÃÀå

Á¦5Àå °æÀï ºÐ¼®

  • Á¦Ç° Æ÷Æ®Æú¸®¿À ºÐ¼®
  • ¿î¿µ»ó ÅëÇÕ
  • PorterÀÇ Five Forces ºÐ¼®

Á¦6Àå ¼ºÀå ±âȸ¿Í Àü·«Àû ºÐ¼®

  • ¼ºÀå ±âȸ ºÐ¼®
    • Á¦Ç°º° ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ÷°¡Á¦ ½ÃÀå ¼ºÀå ±âȸ
    • Áö¿ªº° ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ÷°¡Á¦ ½ÃÀå ¼ºÀå ±âȸ
  • ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ÷°¡Á¦ ½ÃÀåÀÇ »õ·Î¿î µ¿Çâ
  • Àü·«Àû ºÐ¼®
    • ½ÅÁ¦Ç° °³¹ß
    • ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ÷°¡Á¦ ½ÃÀå ´É·Â È®´ë
    • ¼¼°è ¹ÙÀÌ¿ÀÀǾàǰ ÷°¡Á¦ ½ÃÀåÀÇ ÀμöÇÕº´(M&A) ¹× ÇÕÀÛÅõÀÚ(JV)
    • ÀÎÁõ°ú ¶óÀ̼±½Ì

Á¦7Àå À¯·Â ±â¾÷ °³¿ä

  • Merck
  • Colorcon
  • BASF
  • Associated British Foods
  • Signet Excipients
  • Sigachi Industries
  • Spectrum Chemical Manufacturing
  • Roquette Freres
  • IMCD
  • Clariant
LSH 24.03.06

Biopharmaceuticals Exicipents Trends and Forecast

The future of the global biopharmaceuticals exicipents market looks promising with opportunities in the solubilizes & surfactants/emulsifiers, polyols, and carbohydrates markets. The global biopharmaceuticals exicipents market is expected to reach an estimated $4 billion by 2030 with a CAGR of 5.6% from 2024 to 2030. The major drivers for this market are increasing adoption of multifunctional excipients and growing focus of pharmaceutical players on the generic market.

A more than 150-page report is developed to help in your business decisions.

Biopharmaceuticals Exicipents by Segment

The study includes a forecast for the global biopharmaceuticals exicipents by products and region.

Biopharmaceuticals Exicipents Market by Products [Shipment Analysis by Value from 2018 to 2030]:

  • Solubilizes & Surfactants/Emulsifiers
  • Polyols
  • Carbohydrates

Biopharmaceuticals Exicipents Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Biopharmaceuticals Exicipents Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies biopharmaceuticals exicipents companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biopharmaceuticals exicipents companies profiled in this report include-

  • Merck
  • Colorcon
  • BASF
  • Associated British Foods
  • Signet Excipients
  • Sigachi Industries
  • Spectrum Chemical Manufacturing
  • Roquette Freres
  • IMCD
  • Clariant

Biopharmaceuticals Exicipents Market Insights

Lucintel forecasts that carbohydrates will remain the largest segment over the forecast period due to increasing demand for protein therapeutics.

North America will remain the largest region over the forecast period due to substantial need for biopharmaceutical production.

Features of the Global Biopharmaceuticals Exicipents Market

Market Size Estimates: Biopharmaceuticals exicipents market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Biopharmaceuticals exicipents market size by products, region, and region in terms of value ($B).

Regional Analysis: Biopharmaceuticals exicipents market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products and regions for the biopharmaceuticals exicipents market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biopharmaceuticals exicipents market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the biopharmaceuticals exicipents market size?

Answer: The global biopharmaceuticals exicipents market is expected to reach an estimated $4 billion by 2030.

Q2. What is the growth forecast for biopharmaceuticals exicipents market?

Answer: The global biopharmaceuticals exicipents market is expected to grow with a CAGR of 5.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the biopharmaceuticals exicipents market?

Answer: The major drivers for this market are increasing adoption of multifunctional excipients and growing focus of pharmaceutical players on the generic market.

Q4. What are the major segments for biopharmaceuticals exicipents market?

Answer: The future of the biopharmaceuticals exicipents market looks promising with opportunities in the solubilizes & surfactants/emulsifiers, polyols, and carbohydrates markets.

Q5. Who are the key biopharmaceuticals exicipents market companies?

Answer: Some of the key biopharmaceuticals exicipents companies are as follows.

  • Merck
  • Colorcon
  • BASF
  • Associated British Foods
  • Signet Excipients
  • Sigachi Industries
  • Spectrum Chemical Manufacturing
  • Roquette Freres
  • IMCD
  • Clariant

Q6. Which biopharmaceuticals exicipents market segment will be the largest in future?

Answer: Lucintel forecasts that carbohydrates will remain the largest segment over the forecast period due to increasing demand for protein therapeutics.

Q7. In biopharmaceuticals exicipents market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to substantial need for biopharmaceutical production.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the biopharmaceuticals exicipents market by products (solubilizes & surfactants/emulsifiers, polyols, and carbohydrates) and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Biopharmaceuticals Exicipents Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Biopharmaceuticals Exicipents Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Biopharmaceuticals Exicipents Market by Products
    • 3.3.1: Solubilizes & Surfactants/Emulsifiers
    • 3.3.2: Polyols
    • 3.3.3: Carbohydrates

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Biopharmaceuticals Exicipents Market by Region
  • 4.2: North American Biopharmaceuticals Exicipents Market
  • 4.3: European Biopharmaceuticals Exicipents Market
    • 4.3.1: European Biopharmaceuticals Exicipents Market by Products: Solubilizes & Surfactants/Emulsifiers, Polyols, and Carbohydrates
  • 4.4: APAC Biopharmaceuticals Exicipents Market
    • 4.4.1: APAC Biopharmaceuticals Exicipents Market by Products: Solubilizes & Surfactants/Emulsifiers, Polyols, and Carbohydrates
  • 4.5: ROW Biopharmaceuticals Exicipents Market
    • 4.5.1: ROW Biopharmaceuticals Exicipents Market by Products: Solubilizes & Surfactants/Emulsifiers, Polyols, and Carbohydrates

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Biopharmaceuticals Exicipents Market by Products
    • 6.1.2: Growth Opportunities for the Global Biopharmaceuticals Exicipents Market by Region
  • 6.2: Emerging Trends in the Global Biopharmaceuticals Exicipents Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Biopharmaceuticals Exicipents Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biopharmaceuticals Exicipents Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Merck
  • 7.2: Colorcon
  • 7.3: BASF
  • 7.4: Associated British Foods
  • 7.5: Signet Excipients
  • 7.6: Sigachi Industries
  • 7.7: Spectrum Chemical Manufacturing
  • 7.8: Roquette Freres
  • 7.9: IMCD
  • 7.10: Clariant
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦